MedTrace Logo

Analysis of Markers in the Blood Correlated With Neuropathic Pain

NCT02208206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-02-06

No results posted yet for this study

Summary

The purpose of this study is to analyze associations between symptoms and specific markers in the blood in patients suffering from neuropathic pain linked to diseases of different origin. Such markers could be utilized in the future for precise diagnosis of neuropathic pain and might lead to targeted pain treatment.

Conditions

Sponsors & Collaborators

  • deCODE genetics

    collaborator INDUSTRY

  • Christoph Stein, MD

    lead OTHER

Principal Investigators

  • Christoph Stein, Prof. · Department of Anesthesiology Charite

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02208206 on ClinicalTrials.gov